Eye with DNA strands symbolizing genetic link to thyroid eye disease

Decoding Thyroid Eye Disease: Is a Genetic Link the Key to Better Treatments?

Beau Callahan in Health & Wellness December 2025 • 4 min read.

"New research uncovers a potential genetic variant that could increase susceptibility to thyroid eye disease, offering hope for targeted therapies."

Thyroid eye disease (TED), also known as thyroid-associated orbitopathy (TAO), is an autoimmune condition that causes inflammation and damage to the tissues around the eyes. This can lead to a range of symptoms, from mild discomfort and dryness to severe vision impairment and disfigurement. Understanding the factors that contribute to TED is crucial for developing effective treatments and improving the quality of life for those affected.

While Graves' disease, an autoimmune disorder affecting the thyroid gland, is a well-known risk factor for TED, the exact reasons why some individuals with Graves' develop TED while others do not remain unclear. Genetic predisposition is believed to play a significant role, making it essential to identify specific genes that may increase susceptibility to this condition. This knowledge can not only help in predicting who is at higher risk but also in developing targeted therapies that address the root causes of the disease.

Recent research has focused on identifying genetic variants associated with TED in individuals with Graves' disease. This work utilizes advanced techniques like genome-wide association studies (GWAS) to scan the entire genome for genetic markers that are more common in people with TED than in those without it. By identifying these genetic links, researchers aim to unravel the complex mechanisms underlying TED and open new avenues for treatment and prevention.

Unlocking the Genetic Code: How Does This Study Identify Susceptibility to Thyroid Eye Disease?

Eye with DNA strands symbolizing genetic link to thyroid eye disease

A recent genome-wide association study (GWAS) conducted on Australian Caucasian participants has identified a potential genetic link to thyroid eye disease (TED). The study, which pooled DNA samples from 265 participants with Graves' disease and TED (cases) and 147 patients with Graves' disease without TED (controls), aimed to uncover genetic variants associated with increased susceptibility to TED.

The initial GWAS of pooled DNA samples revealed several single nucleotide polymorphisms (SNPs) showing suggestive associations with TED. SNPs are variations in a single nucleotide that occur at a specific position in the genome and can be used as genetic markers. However, the only SNP that consistently showed association with TED on individual genotyping in both the discovery and replication cohorts was rs6110809.

rs953128 located on chr10q21.1
rs2867161 on chr7q11.22
rs13360861 on chr5q12.3
rs7636326 on chr3q26.2
rs10266576 on chr 7q11.22
rs60457622 on chr3q23
rs6110809 on chr20p12.1

The SNP rs6110809 is located within the MACROD2 gene on chromosome 20p12.1. Further analysis of discovery and replication cohorts showed that the minor A allele of rs6110809 was more frequent in individuals with TED than in Graves' disease controls without TED. After adjusting for factors like age, sex, duration of Graves' disease, and smoking, the association remained significant, suggesting that this genetic variant may increase susceptibility to TED in patients with Graves' disease.

What's Next? Confirming the Link and Exploring New Treatments

The discovery of the MACROD2 genetic variant as a potential susceptibility factor for thyroid eye disease opens up new avenues for research and treatment. While these findings are promising, further studies are needed to confirm the association in additional independent cohorts and to fully understand the functional role of MACROD2 in the development of TED. Future research may also focus on exploring the potential of MACROD2 as a therapeutic target, leading to the development of new and more effective treatments for this debilitating condition.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What exactly is thyroid eye disease, and why is it important to understand it?

Thyroid eye disease, also known as thyroid-associated orbitopathy, is an autoimmune condition where the tissues around the eyes become inflamed and damaged. It's significant because it can cause a range of problems, from mild discomfort to severe vision impairment. The implications of TED can greatly affect a person's quality of life, making it crucial to understand and treat the condition effectively. While the connection between Graves' disease and TED is known, further research aims to clarify why some individuals with Graves' develop TED and others do not.

What are genome-wide association studies (GWAS), and how are they used in the context of thyroid eye disease?

Genome-wide association studies (GWAS) are used to scan the entire genome to find genetic markers that are more common in people with thyroid eye disease (TED) than in those without it. GWAS are important because they help identify specific genes that may increase a person's susceptibility to TED. By pinpointing these genetic links, researchers can better understand the underlying mechanisms of TED, potentially leading to new treatments and prevention strategies. Techniques like individual genotyping is conducted to validate single nucleotide polymorphisms (SNPs).

What are SNPs, and how do they relate to genetic susceptibility of thyroid eye disease?

SNPs, or single nucleotide polymorphisms, are variations in a single nucleotide at a specific position in the genome. They're important genetic markers that can be used to study the genetic basis of diseases like thyroid eye disease (TED). SNPs can help identify genetic variants associated with increased susceptibility to TED, allowing for a better understanding of the disease's underlying mechanisms. One such SNP is rs6110809, located within the MACROD2 gene.

What is rs6110809, and why is it significant in thyroid eye disease research?

rs6110809 is a single nucleotide polymorphism (SNP) located within the MACROD2 gene on chromosome 20p12.1. It's significant because research suggests that the minor A allele of rs6110809 is more frequent in individuals with thyroid eye disease (TED) than in those with Graves' disease but without TED. This suggests that this genetic variant may increase susceptibility to TED in patients with Graves' disease, making it a potential target for further research and treatment development.

Why is identifying the MACROD2 genetic variant important, and what are the implications for future research and treatment of thyroid eye disease?

The discovery of the MACROD2 genetic variant as a potential susceptibility factor for thyroid eye disease (TED) opens up new avenues for research and treatment. It's important because it provides a specific target for further investigation into the underlying mechanisms of TED. The implication of this discovery is that future research may focus on exploring the potential of MACROD2 as a therapeutic target, leading to the development of new and more effective treatments for TED. However, the functional role of MACROD2 in the development of TED still needs further investigation.